Table of Contents Table of Contents
Previous Page  193 / 400 Next Page
Information
Show Menu
Previous Page 193 / 400 Next Page
Page Background

MONDAY

TUESDAY

WEDNESDAY

THURSDAY

German language Session 

 Q&A Modul

SCIENTIFIC PROGRAMME

185

002

Depression and emergent dementia – common

pathways in frequent psychiatric disorders of old age

Alistair Burns, United Kingdom

003

The neurodegenerative dementias – the neuro-

logical view on early diagnosis and classification

Reinhold Schmidt, Austria

S-264

Symposium

11:45– 13:15

|

Hall Helsinki 1

TOPIC 13:

Brain imaging, neurophysiology,

neuropsychology

Integrating resting state EEG in psychiatric clinical

practice: past, present and future developments

WPA Section: Psychiatric Electrophysiology

Chairs:

Oliver Pogarell, Germany

Nashaat Boutros, USA

001

EEG and neurocognitive markers of psychosis

vulnerability

Tomiki Sumiyoshi, Japan

002

EEG in decision making and reward processing

– from differential diagnosis to treatment

Oliver Pogarell, Germany

003

What insights can the EEG provide when treating

individuals with autism spectrum disorder?

Ron Swatzyna, USA

004

EEGs and panic attacks – the old and the new

stories

Nashaat Boutros, USA

Jocelyn Pearson, Zachary Thomas

S-265

Symposium

11:45– 13:15

|

Hall Helsinki 2

TOPIC 11:

Other disorders

Tricky cases: case histories out of the spectrum of

psychiatric disorders

Chairs:

Sibylle Häfner, Germany

Gareth Owen, United Kingdom

001

Case 1

Larry Rifkin, Germany

002

Case 2

Ludger Tebartz van Elst, Germany

003

Case 3

Nikola Kern, United Kingdom

004

Case 4

Felix Wedegärtner, Germany

S-266

Symposium

11:45– 13:15

|

Hall Paris 1

TOPIC 4:

Affective disorders

The future of psychoneuroimmunology: promises

and challenges

WPA Section: Immunology & Psychiatry

Chairs:

Angelos Halaris, USA

Karl Bechter, Germany

001

Autoimmune encephalitis and mild encephalitis

– new challenges in psychoneuroimmunology

Karl Bechter, Germany

002

Use of magnetic resonance spectroscopy and

multimodal brain imaging to map brain response to

inflammation in mood disorders

Ebrahim Haroon, USA

003

Utility of the arachidonic acid cascade to

establish treatment resistance in major depressive

disorder

Fotini Boufidou, Greece

004

Stratification and differentiation of mood

disorders by means of inflammation and growth

factor biomarkers

Angelos Halaris, USA

S-267

Symposium

11:45– 13:15

|

Hall Paris 2

TOPIC 13:

Brain imaging, neurophysiology,

neuropsychology

Brain networks in health and disease

Chairs:

Urs Braun, Germany

Martin Walter, Germany

001

Brain networks in depression

Martin Walter, Germany

002

Translational aspects of brain networks

Christian Clemm von Hohenberg, Germany

003

Dynamic brain networks and schizophrenia

Urs Braun, Germany

004

Networks shaped by gene expression

Ingrid Romme, The Netherlands